Natixis Advisors, LLC’s Abbott Laboratories Position
Does Natixis Advisors, LLC own Abbott Laboratories (ABT)? Yes — 1.74M shares worth $178M (+0.25% of its 13F portfolio) as of Q1 2026, up from 1.58M shares the prior filed quarter.
Position Value
$178M
Q1 2026
Shares
1.74M
% of Portfolio
+0.25%
Quarters Held
30
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 1.74M | $178M | +0.25% |
| Q4 2025 | 1.58M | $199M | +0.28% |
| Q3 2025 | 1.77M | $237M | +0.35% |
| Q2 2025 | 1.73M | $235M | +0.37% |
| Q1 2025 | 1.60M | $213M | +0.39% |
| Q4 2024 | 1.59M | $180M | +0.34% |
| Q3 2024 | 1.42M | $162M | +0.32% |
| Q2 2024 | 1.22M | $127M | +0.28% |
| Q1 2024 | 976.3K | $111M | +0.26% |
| Q4 2023 | 965.9K | $106M | +0.28% |
| Q3 2023 | 702.7K | $68M | +0.21% |
| Q2 2023 | 1.12M | $123M | +0.38% |
| Q1 2023 | 906.3K | $92M | +0.32% |
| Q4 2022 | 1.07M | $117M | +0.44% |
| Q3 2022 | 991.1K | $96M | +0.41% |
| Q2 2022 | 853.7K | $93M | +0.41% |
| Q1 2022 | 919.4K | $109M | +0.41% |
| Q4 2021 | 911.3K | $128M | +0.49% |
| Q3 2021 | 857.7K | $101M | +0.42% |
| Q2 2021 | 827.5K | $96M | +0.45% |
| Q1 2021 | 796.5K | $95M | +0.50% |
| Q4 2020 | 774.6K | $85M | +0.49% |
| Q3 2020 | 643.1K | $70M | +0.44% |
| Q2 2020 | 677.8K | $62M | +0.41% |
| Q1 2020 | 551.8K | $44M | +0.35% |
| Q4 2019 | 535.5K | $47M | +0.33% |
| Q3 2019 | 466.0K | $39M | +0.31% |
| Q2 2019 | 423.9K | $36M | +0.29% |
| Q1 2019 | 450.2K | $36M | +0.32% |
| Q4 2018 | 441.8K | $32M | +0.32% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Natixis Advisors, LLC’s full portfolio or all institutional holders of ABT.